Bio Banter: What's Happening in the Biotech Markets
A Call Featuring Michael Margolis, R.Ph., Co-Head of Healthcare Investment Banking, and Jared Holz, Chief Healthcare Market Strategist at Oppenheimer
In this episode, "Bio Banter: What's Happening in the Biotech Markets," Michael Margolis, R.Ph., Co-Head of Healthcare Investment Banking, and Jared Holz, Chief Healthcare Market Strategist at Oppenheimer, discuss the biotechnology market by addressing the life sciences equities markets, and what the future may have in store for this dynamic sector.
Episode Highlights Include:
The past few years have brought explosive growth in the number of life sciences companies and investors; however, after ending 2021 on a down note, and experiencing a turbulent January, many investors had hopes for stronger momentum in 2022 – especially given the sector’s advancing innovations. In this episode, guest expert Jared Holz, Chief Healthcare Market Strategist at Oppenheimer, provides insights into where things might begin to look up for investors.
Have Investors Lost Their Edge Due to Lockdowns?
Before the pandemic, investors successfully interacted with colleagues and key thought leaders through medical conferences and site visits. Through these events, core relationships were developed with company management. However, investors may have lost their edge due to pandemic-related lockdowns and new social distancing policies.
So, we must ask: how successful can investors be while only using Zoom and not interacting in person? Jared Holz shares his future-forward perspective as more businesses begin to open up with strides toward a new normal.
Join the Conversation
Tell us what you want to hear. Oppenheimer's Let's Talk Future podcast series invites engaging conversations surrounding the markets, innovations, and life in general. Leave a review on our Apple Podcast Platform or let us know what interests you by writing to Oppenheimer's Marketing Department at email@example.com.
This podcast is the property of Oppenheimer & Co. Inc. and should not be copied, distributed, published or reproduced, in whole or in part. The information/commentary contained in this recording was obtained from market conditions and professional sources, and is educational in nature. The information presented has been derived from sources believed to be reliable but is not guaranteed as to accuracy and does not purport to be a complete analysis of any strategy, plan, security, company, or industry involved. Opinions expressed herein are subject to change without notice. Oppenheimer has no obligation to provide any updates or changes. Any examples used in this material are generic, hypothetical and for illustration purposes only. All price references and market forecasts are as of the date of recording. This podcast is not a product of Oppenheimer Research, nor does it provide any financial, economic, legal, accounting, or tax advice or recommendations. Any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed.
Securities and other financial instruments that may be discussed in this report or recommended or sold are not insured by the Federal Deposit Insurance Corporation and are not deposits or obligations of any insured depository institution. Investments involve numerous risks including market risk, counterparty default risk and liquidity risk. Securities and other financial investments at times maybe difficult to value or sell. The value of financial instruments may fluctuate, and investors may lose their entire principal investment. Prior to making any investment or financial decisions, an investor should seek advice from their personal financial, legal, tax and other professional advisors that take into account all of the particular facts and circumstances of an investor's own situation. The views and strategies described may not be suitable for all investors. This report does not take into account the investment objectives, financial situation or specific needs of any particular client of Oppenheimer or its affiliates.
This presentation may contain forward looking statements or projections regarding future events. Forward-looking statements and projections are based on the opinions and estimates of Oppenheimer as of the date of this podcast, and are subject to a variety of risks and uncertainties as well as other factors, including economic, political, and public health factors, that could cause actual events or results to differ materially from those anticipated in the forward-looking statements and projections. Past performance does not guarantee future results.
The performance of a benchmark index is not indicative of the performance of any particular investment; however, they are considered representative of their respective market segments. Please note that indexes are unmanaged and their returns do not take into account any of the costs associated with buying and selling individual securities. Individuals cannot invest directly in an index.
Oppenheimer Transacts Business on all Principal Exchanges and Member SIPC 4265083.1